Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Development of noninvasive, reliable biomarkers for lung cancer diagnosis has many clinical benefits knowing that most of lung cancer patients are diagnosed at the late stage. For this purpose, we conducted proteomic analyses of 231 human urine samples in healthy individuals (n=33), benign pulmonary diseases (n=40), lung cancer (n=33), bladder cancer (n=17), cervical cancer (n=25), colorectal cancer (n=22), esophageal cancer (n=14), and gastric cancer (n=47) patients collected from multiple medical centers. By random forest modeling, we nominated a list of urine proteins that could separate lung cancers from other cases. With a feature selection algorithm, we selected a panel of five urinary biomarkers (FTL: Ferritin light chain; MAPK1IP1L: Mitogen-Activated Protein Kinase 1 Interacting Protein 1 Like; FGB: Fibrinogen Beta Chain; RAB33B: RAB33B, Member RAS Oncogene Family; RAB15: RAB15, Member RAS Oncogene Family) and established a combinatorial model that can correctly classify the majority of lung cancer cases both in the training set (n=46) and the test sets (n=14-47 per set) with an AUC ranging from 0.8747 to 0.9853. A combination of five urinary biomarkers not only discriminates lung cancer patients from control groups but also differentiates lung cancer from other common tumors. The biomarker panel and the predictive model, when validated by more samples in a multi-center setting, may be used as an auxiliary diagnostic tool along with imaging technology for lung cancer detection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“Protein abundance was measured as iBAQ (intensity-based absolute quantification) - a label-free quantification algorithm (Schwanhausser et al., 2011).”
MethodCancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066 · cited 3×
“Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two main histologic subtypes of lung cancer with the NSCLC as the most common subtype, accounting for about 83% of all lung cancers (Miller et al., 2016).”
BackgroundInfluentialMissing Value Estimation Methods for DNA Microarrays
Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani, R., Botstein, D., & Altman, R. B. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.6.520 · Cited by 4,230
Rab GTPases as coordinators of vesicle traffic
Stenmark, H. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2728 · Cited by 3,413 · cited 1×
“RAB14 (Member RAS Oncogene Family), together with RAB15 and RAB33B are Rab GTPases, a family of small GTPases which mainly functions in controlling intracellular membrane trafficking (Hutagalung and Novick, 2011, Zhen and Stenmark, 2015, Stenmark, 2009).”
BackgroundVariable selection using random forests
Genuer, R., Poggi, J.-M., & Tuleau-Malot, C. (2010) · Pattern Recognition Letters · doi:10.1016/j.patrec.2010.03.014 · Cited by 2,619
Fibrinogen and fibrin structure and functions
MOSESSON, M. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01365.x · Cited by 1,695 · cited 1×
“The high correlation of FGG (Fibrinogen Gamma Chain), and FGA (Fibrinogen Alpha Chain) with FGB was expected as they are components of fibrinogen, a glycoprotein that is essential for blood clot formation (Mosesson, 2005).”
BackgroundIdentification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma
Radon, T. P., Massat, N. J., Jones, R., Alrawashdeh, W., Dumartin, L., Ennis, D., Duffy, S. W., Kocher, H. M., Pereira, S. P., Guarner (posthumous), L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2467 · Cited by 203 · cited 1×
“…single biomarker may hardly achieve satisfactory discriminating power due to the tumor heterogeneity, seeking multiple biomarkers and developing a combinatorial model for cancer detection is hence a desirable strategy as demonstrated by some earlier studies (Patz et al., 2007, Radon et al., 2015).”
Method
Cited by
Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
Macklin, A., Khan, S., & Kislinger, T. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-09283-w · Cited by 317
Cancer metabolomic markers in urine: evidence, techniques and recommendations
Dinges, S. S., Hohm, A., Vandergrift, L. A., Nowak, J., Habbel, P., Kaltashov, I. A., & Cheng, L. L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0185-3 · Cited by 161
Application of Artificial Intelligence in Lung Cancer
Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M. (2022) · Cancers · doi:10.3390/cancers14061370 · Cited by 138
“To handle the extremely large number of variables produced by proteomics, researchers have used machine learning methods to reduce dimensionality and feature selection [35,36].”
MethodUrine proteome of COVID-19 patients
(2020) · doi:10.1016/j.urine.2021.02.001 · Cited by 68
Liu, Y., Xia, Y., Smollar, J., Mao, W., & Wan, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188539 · Cited by 23
Metadata
- Authors
- Zhang, C., Leng, W., Sun, C., Lu, T., Chen, Z., Men, X., Wang, Y., Wang, G., Zhen, B., & Qin, J.
- Venue
- eBioMedicine
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 30
- Pages
- 120-128
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W2792932731
- Cited by
- 128
- References
- 8
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors. https://app.cochat.ai/papers/10.1016/j.ebiom.2018.03.009
- The paper
- Zhang, C., Leng, W., Sun, C., Lu, T., Chen, Z., Men, X., Wang, Y., Wang, G., Zhen, B., & Qin, J. (2018). Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors. eBioMedicine. https://doi.org/10.1016/j.ebiom.2018.03.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.